Science Explorer Interactive view Map
Company · Paris · France

OSE Immunotherapeutics (France)

Research works
88
▲ 219% vs 2013–17
Citations
1.2k
13.9 per fractional work
Top-10% rate
8.8%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: OSE Immunotherapeutics (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.56× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 19.20× its world share, 5 worksImmunology and Micro…Neuroscience: 0.03× its world share, 0 worksNeuroscienceChemistry: 0.19× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 0.06× its world share, 0 worksMathematicsDentistry: 0.90× its world share, 0 worksDentistryHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.63× its world share, 14 worksMedicineEconomics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychologySocial Sciences: 0.29× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 19.2×. Every wedge is a field page.

Who are the top researchers at OSE Immunotherapeutics (France)?

Ranked on the composite score, Nicolas Poirier lead among researchers whose main affiliation is OSE Immunotherapeutics (France).

  1. 1 Nicolas Poirier France · #895,157 worldwide 36 citations · 17 works
All ranked researchers at OSE Immunotherapeutics (France)

Which keywords describe research at OSE Immunotherapeutics (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Tumor Microenvironment, Tumor Regression, Immune Checkpoint Blockade, PD-1 and PD-L1, Gene Therapy and Inflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Immunotherapy5▲ 23×7 topics
  2. Cancer Immunotherapy4▲ 106×3 topics
  3. Tumor Microenvironment4▲ 35×4 topics
  4. Tumor Regression4▲ 128×2 topics
  5. Immune Checkpoint Blockade4▲ 116×1 topic
  6. PD-1 and PD-L14▲ 116×1 topic
  7. Inflammation3▲ 5.7×14 topics
  8. Gene Therapy3▲ 57×3 topics
  9. Lymphoma3▲ 62×3 topics
  10. Immunity3▲ 24×3 topics
  11. Epidemiology3▲ 2.4×12 topics
  12. CAR T Cells2▲ 114×1 topic
  13. Chimeric Antigen Receptor2▲ 114×1 topic
  14. Innate Immunity2▲ 26×3 topics
  15. Antigen Presentation2▲ 86×2 topics
  16. Dendritic Cells2▲ 77×1 topic
  17. Tumor Antigen2▲ 112×1 topic
  18. Cancer2▲ 4.6×7 topics
  19. Inflammatory Bowel Disease2▲ 54×2 topics
  20. Tumor Targeting2▲ 34×3 topics
  21. Arginine Deprivation2▲ 155×1 topic
  22. Bacterial Therapy2▲ 155×1 topic
  23. Glycosylation1▲ 45×3 topics
  24. Pathogenesis1▲ 10×3 topics
  25. Genetics1▲ 6.8×2 topics
  26. Diagnosis1▲ 4.5×6 topics
  27. Monoclonal Antibodies1▲ 47×3 topics
  28. RNA Interference1▲ 52×2 topics
  29. Antibody Engineering1▲ 74×1 topic
  30. Fc Receptors1▲ 74×1 topic
  31. Gene Silencing1▲ 39×1 topic
  32. Therapeutic Antibodies1▲ 59×2 topics
  33. siRNA Delivery1▲ 64×1 topic
  34. Children1▲ 16×2 topics
  35. Environmental Participation1▲ 45×1 topic
  36. Management1▲ 4.8×3 topics
  37. Territorial Governance1▲ 29×1 topic

Which research topics does OSE Immunotherapeutics (France) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses and Cancer Research and Treatments.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 2 works
  4. 4 Cancer Research and Treatments Biotechnology 2 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 French Urban and Social Studies Sociology and Political Science 1 works
  8. 8 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  9. 9 Inflammatory Bowel Disease Genetics 1 works
  10. 10 Microscopic Colitis Epidemiology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 28% of research is openly available.

with international co-authors35.3%domestic only64.7%

World: 19% is written across borders.

How has OSE Immunotherapeutics (France)'s research output changed?

Output in 2018–2022 was 219% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.